Drug Type Chemical drugs |
Synonyms ΕΡΙ 002, ΕΡΙ002 |
Target |
Mechanism RIPK1 inhibitors(Receptor-interacting serine/threonine-protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alopecia | Preclinical | KR | 15 Apr 2024 |